THC Gummies and Drinks Could Lose Federal Hemp Status Under New Law

Proposed Law Targets Semi-Synthetic Cannabinoids

The legislation would amend 21 U.S.C. § 802 to explicitly exclude chemically derived or semi-synthetic cannabinoids from the definition of hemp, closing the loophole that's allowed delta-8 THC and similar compounds to proliferate since 2018. Semi-synthetic cannabinoids, under the bill's definition, are those produced through isomerization, chemical synthesis, or other laboratory processes that convert CBD or other hemp-derived compounds into intoxicating substances.

Products containing these cannabinoids would be classified as Schedule I controlled substances unless the source plant itself naturally produces them in concentrations above 0.3% delta-9 THC. That threshold would effectively ban the vast majority of hemp-derived intoxicating products currently sold in gas stations, convenience stores, and online retailers across all 50 states. No exceptions.

The bill's sponsors argue the 2018 Farm Bill never intended to legalize intoxicating products. Congress defined hemp solely by its delta-9 THC content, not anticipating that manufacturers would chemically convert non-intoxicating CBD into delta-8 THC and other analogs.

Multi-Billion Dollar Hemp Market at Risk

The U.S. intoxicating hemp market generated an estimated $2.8 billion in retail sales in 2025, with delta-8 THC products accounting for roughly 60% of that total. Industry data shows more than 15,000 retail locations nationwide carry these products, from dedicated hemp shops to major convenience-store chains.

If this bill passes, the entire supply chain collapses overnight — manufacturers, distributors, and retailers would face immediate criminal liability for possessing what are suddenly Schedule I substances.

The legislation includes no grandfather clause or transition period. Products legal today would become contraband the moment the President signs the bill into law. Retailers holding inventory would be required to destroy it or transfer it to DEA-registered facilities. Continued sales would constitute federal drug trafficking.

State-Legal Cannabis Programs Unaffected

The bill doesn't alter state-licensed cannabis programs operating under medical or adult-use frameworks; those remain governed by existing state law and federal enforcement policy. The target is exclusively hemp-derived products sold outside state cannabis regulatory systems.

Thirty-eight states have legalized cannabis in some form as of August 2026, but many of those states have simultaneously struggled to regulate or ban intoxicating hemp products that undercut licensed dispensaries. The federal bill would effectively resolve that tension by removing the products from commerce entirely, though it would also eliminate a revenue stream for hemp farmers and processors who've invested heavily in extraction and conversion infrastructure since 2018.

Legislative Path and Timing

The bill was introduced in both chambers on August 24, 2026, with bipartisan co-sponsors in the Senate and broad support from state attorneys general who've called the hemp loophole a public-health crisis. Senate Majority Leader has signaled the bill could reach the floor by mid-September. The White House hasn't indicated whether the President would sign or veto the measure.

Industry groups have begun mobilizing opposition, arguing the bill conflates responsible hemp businesses with illicit operators and that a regulatory framework would be preferable to an outright ban. No such framework is included in the current draft. For full background on this story, see the CannIntel topic hub on the federal hemp loophole.

The next signal: committee markup in the Senate Agriculture Committee, expected within two weeks. If the bill advances, the intoxicating hemp sector will have less than 60 days to pivot or shutter.